• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment


24.1750 USD 0.2150 0.90%

As of 20:10:00 ET on 11/26/2014.

Snapshot for QIAGEN NV (QGEN)

Open: 23.9100 Day's Range: 23.8800 - 24.1900 Volume: 419,969
Previous Close: 23.9600 52wk Range: 19.4600 - 25.3200 1-Yr Rtn: +3.80%

Stock Chart for QGEN

No chart data available.
  • QGEN:US 24.1750
  • 1D
  • 1M
  • 1Y
Interactive QGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QGEN

Current P/E Ratio (ttm) 35.6774
Estimated P/E(12/2014) 22.4050
Relative P/E vs. SPX 1.9437
Earnings Per Share (USD) (ttm) 0.6776
Est. EPS (USD) (12/2014) 1.0790
Est. PEG Ratio 2.1942
Market Cap (M USD) 5,615.85
Shares Outstanding (M) 232.30
30 Day Average Volume 649,428
Price/Book (mrq) 2.0853
Price/Sale (ttm) 4.2721
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QGEN

QIAGEN N.V. provides sample and assay technologies. The Company's technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.

Peer M SchatzCEO/Managing DirectorRoland SackersCFO/Managing Director
Dietrich HauffeSenior VP:Life Sciences BusDouglas LiuSenior VP:Global Operations
More Company Profile & Key Executives for QGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • QGEN News

  • Industry News

Sponsored Links
sec ||= nil